vs
Side-by-side financial comparison of Concentra Group Holdings Parent, Inc. (CON) and ILLUMINA, INC. (ILMN). Click either name above to swap in a different company.
ILLUMINA, INC. is the larger business by last-quarter revenue ($1.1B vs $569.6M, roughly 1.9× Concentra Group Holdings Parent, Inc.). ILLUMINA, INC. runs the higher net margin — 12.3% vs 9.2%, a 3.1% gap on every dollar of revenue. On growth, Concentra Group Holdings Parent, Inc. posted the faster year-over-year revenue change (13.7% vs 4.8%). ILLUMINA, INC. produced more free cash flow last quarter ($251.0M vs $9.9M).
Concentra Inc., is a national health care establishment centered around occupational health. It was founded in 1979 in Amarillo, Texas, and the headquarters of the corporation is in Addison, Texas. It runs 627 occupational health centers and 410 onsite health clinics at employer worksites across 47 states. According to the Bureau of Labor Statistics, Concentra treats one out of every seven occupational injuries in the United States. It is currently a publicly traded company with over 80% of t...
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
CON vs ILMN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2027
| Metric | | |
|---|---|---|
| Revenue | $569.6M | $1.1B |
| Net Profit | $52.3M | $134.0M |
| Gross Margin | — | 66.1% |
| Operating Margin | 16.8% | 19.2% |
| Net Margin | 9.2% | 12.3% |
| Revenue YoY | 13.7% | 4.8% |
| Net Profit YoY | 28.7% | — |
| EPS (diluted) | $0.39 | $0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $569.6M | $1.1B | ||
| Q4 25 | $539.1M | $1.2B | ||
| Q3 25 | $572.8M | — | ||
| Q2 25 | $550.8M | — | ||
| Q1 25 | $500.8M | — | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $489.6M | $1.1B | ||
| Q2 24 | $477.9M | $1.1B |
| Q1 26 | $52.3M | $134.0M | ||
| Q4 25 | $34.7M | $334.0M | ||
| Q3 25 | $48.3M | — | ||
| Q2 25 | $44.6M | — | ||
| Q1 25 | $38.9M | — | ||
| Q4 24 | — | $186.0M | ||
| Q3 24 | $44.3M | $705.0M | ||
| Q2 24 | $51.7M | $-2.0B |
| Q1 26 | — | 66.1% | ||
| Q4 25 | — | 65.5% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 65.9% | ||
| Q3 24 | — | 69.0% | ||
| Q2 24 | — | 64.8% |
| Q1 26 | 16.8% | 19.2% | ||
| Q4 25 | 12.9% | 17.4% | ||
| Q3 25 | 16.5% | — | ||
| Q2 25 | 16.3% | — | ||
| Q1 25 | 16.0% | — | ||
| Q4 24 | — | 15.8% | ||
| Q3 24 | 17.6% | 68.6% | ||
| Q2 24 | 17.6% | -147.2% |
| Q1 26 | 9.2% | 12.3% | ||
| Q4 25 | 6.4% | 28.8% | ||
| Q3 25 | 8.4% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 7.8% | — | ||
| Q4 24 | — | 16.8% | ||
| Q3 24 | 9.1% | 65.3% | ||
| Q2 24 | 10.8% | -178.8% |
| Q1 26 | $0.39 | $0.87 | ||
| Q4 25 | $0.27 | $2.16 | ||
| Q3 25 | $0.38 | — | ||
| Q2 25 | $0.35 | — | ||
| Q1 25 | $0.30 | — | ||
| Q4 24 | — | $1.16 | ||
| Q3 24 | $0.37 | $4.42 | ||
| Q2 24 | $0.50 | $-12.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.2B |
| Total DebtLower is stronger | $1.6B | — |
| Stockholders' EquityBook value | $424.7M | $2.7B |
| Total Assets | $2.9B | $6.6B |
| Debt / EquityLower = less leverage | 3.68× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.2B | ||
| Q4 25 | $79.9M | $1.6B | ||
| Q3 25 | $49.9M | — | ||
| Q2 25 | $73.9M | — | ||
| Q1 25 | $52.1M | — | ||
| Q4 24 | — | $93.0M | ||
| Q3 24 | $136.8M | $70.0M | ||
| Q2 24 | $50.7M | $74.0M |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $3.0M | — |
| Q1 26 | $424.7M | $2.7B | ||
| Q4 25 | $393.3M | $2.7B | ||
| Q3 25 | $385.5M | — | ||
| Q2 25 | $342.6M | — | ||
| Q1 25 | $307.1M | — | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | $277.8M | $2.1B | ||
| Q2 24 | $1.2B | $1.4B |
| Q1 26 | $2.9B | $6.6B | ||
| Q4 25 | $2.9B | $6.6B | ||
| Q3 25 | $2.8B | — | ||
| Q2 25 | $2.8B | — | ||
| Q1 25 | $2.7B | — | ||
| Q4 24 | — | $6.3B | ||
| Q3 24 | $2.5B | $6.0B | ||
| Q2 24 | $2.4B | $6.1B |
| Q1 26 | 3.68× | — | ||
| Q4 25 | 3.98× | — | ||
| Q3 25 | 4.15× | — | ||
| Q2 25 | 4.82× | — | ||
| Q1 25 | 5.27× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.30× | — | ||
| Q2 24 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $21.0M | $289.0M |
| Free Cash FlowOCF − Capex | $9.9M | $251.0M |
| FCF MarginFCF / Revenue | 1.7% | 23.0% |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 0.40× | 2.16× |
| TTM Free Cash FlowTrailing 4 quarters | $211.0M | $1.1B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $21.0M | $289.0M | ||
| Q4 25 | $118.7M | $321.0M | ||
| Q3 25 | $60.6M | — | ||
| Q2 25 | $88.4M | — | ||
| Q1 25 | $11.7M | — | ||
| Q4 24 | — | $364.0M | ||
| Q3 24 | $65.9M | $316.0M | ||
| Q2 24 | — | $80.0M |
| Q1 26 | $9.9M | $251.0M | ||
| Q4 25 | $98.5M | $267.0M | ||
| Q3 25 | $39.4M | — | ||
| Q2 25 | $63.2M | — | ||
| Q1 25 | $-4.0M | — | ||
| Q4 24 | — | $335.0M | ||
| Q3 24 | $50.8M | $284.0M | ||
| Q2 24 | — | $49.0M |
| Q1 26 | 1.7% | 23.0% | ||
| Q4 25 | 18.3% | 23.0% | ||
| Q3 25 | 6.9% | — | ||
| Q2 25 | 11.5% | — | ||
| Q1 25 | -0.8% | — | ||
| Q4 24 | — | 30.3% | ||
| Q3 24 | 10.4% | 26.3% | ||
| Q2 24 | — | 4.4% |
| Q1 26 | — | — | ||
| Q4 25 | 3.7% | — | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 4.6% | — | ||
| Q1 25 | 3.1% | — | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | 3.1% | 3.0% | ||
| Q2 24 | — | 2.8% |
| Q1 26 | 0.40× | 2.16× | ||
| Q4 25 | 3.42× | 0.96× | ||
| Q3 25 | 1.26× | — | ||
| Q2 25 | 1.98× | — | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | — | 1.96× | ||
| Q3 24 | 1.49× | 0.45× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CON
| Workers' compensation | $337.7M | 59% |
| Employer services | $172.4M | 30% |
| Onsite health clinics | $37.2M | 7% |
| Other | $14.5M | 3% |
| Consumer health | $7.8M | 1% |
ILMN
| Product revenue | $917.0M | 84% |
| Service and other revenue | $174.0M | 16% |
